EIKN
Eikon Therapeutics, Inc.
EIKN • XNAS
Eikon Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on XNAS, led by CEO Roger Perlmutter, with a market cap of $529.6M.
CEORoger Perlmutter
Next Earnings
No upcoming earnings scheduled for Eikon Therapeutics, Inc.
No earnings announcement scheduled
Earnings History
Past 1 earnings report for Eikon Therapeutics, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 30, 2026 | Q4 2025 | -$1.48Est: -$1.58 | +6.3% | - | — |  10-K |